BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2116739)

  • 21. Utility of liquid chromatography/fast atom bombardment mass spectrometry and liquid chromatography/thermospray mass spectrometry for structure identification of metabolites of a fluorinated herbicide.
    Fujiwara H; Chott RC; Solsten RT
    Biol Mass Spectrom; 1992 Sep; 21(9):431-40. PubMed ID: 1420380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement by HPLC of desferrioxamine-available iron in rabbit kidneys to assess the effect of ischaemia on the distribution of iron within the total pool.
    Gower J; Healing G; Green C
    Free Radic Res Commun; 1989; 5(4-5):291-9. PubMed ID: 2707629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron-chelating agents never suppress Fenton reaction but participate in quenching spin-trapped radicals.
    Li L; Abe Y; Kanagawa K; Shoji T; Mashino T; Mochizuki M; Tanaka M; Miyata N
    Anal Chim Acta; 2007 Sep; 599(2):315-9. PubMed ID: 17870296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxamate-based iron chelators: combinatorial syntheses of desferrioxamine B analogues and evaluation of binding affinities.
    Poreddy AR; Schall OF; Osiek TA; Wheatley JR; Beusen DD; Marshall GR; Slomczynska U
    J Comb Chem; 2004; 6(2):239-54. PubMed ID: 15002973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators.
    Rossi NA; Mustafa I; Jackson JK; Burt HM; Horte SA; Scott MD; Kizhakkedathu JN
    Biomaterials; 2009 Feb; 30(4):638-48. PubMed ID: 18977029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
    Richardson D; Ponka P; Baker E
    Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of desferrioxamine-available iron in biological tissues by high-pressure liquid chromatography.
    Gower JD; Healing G; Green CJ
    Anal Biochem; 1989 Jul; 180(1):126-30. PubMed ID: 2817334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N,N'-bis-(3,4,5-trimethoxybenzyl) ethylenediamine N,N'-diacetic acid as a new iron chelator with potential medicinal applications against oxidative stress.
    Galey JB; Dumats J; Genard S; Destree O; Pichaud P; Cctroux P; Marrot L; Beck I; Fernandez B; Barre G
    Biochem Pharmacol; 1996 Jan; 51(2):103-15. PubMed ID: 8615878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of iron chelators in thalassemia and sickle cell disease: a multiple treatment comparison network meta-analysis and trial sequential analysis.
    Sridharan K; Sivaramakrishnan G
    Expert Rev Clin Pharmacol; 2018 Jun; 11(6):641-650. PubMed ID: 29727586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network.
    Ricchi P; Meloni A; Pistoia L; Spasiano A; Spiga A; Allò M; Gamberini MR; Lisi R; Campisi S; Peluso A; Missere M; Renne S; Mangione M; Positano V; Pepe A
    Ann Hematol; 2018 Oct; 97(10):1925-1932. PubMed ID: 29926157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validated HPLC assay for iron determination in biological matrices based on ferrioxamine formation.
    Tesoro A; Novakovic J; Thiessen JJ; Spino M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):177-83. PubMed ID: 16023418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term comparative studies in thalassemia patients treated with deferoxamine or a deferoxamine/deferiprone combination. Identification of effective chelation therapy protocols.
    Kolnagou A; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2008; 32(1-2):41-7. PubMed ID: 18274982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry.
    Przybylski M
    Arzneimittelforschung; 1982; 32(9):995-1012. PubMed ID: 6756419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of iron chelating agent on Schistosoma mansoni infected murine model.
    Abdelgelil NH; Abdellatif MZM; Abdel-Hafeez EH; Belal US; Mohamed RM; Abdel-Razik AH; Hassanin KMA; Abdel-Wahab A
    Biomed Pharmacother; 2019 Jan; 109():28-38. PubMed ID: 30391706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo efficacy, toxicity and biodistribution of ultra-long circulating desferrioxamine based polymeric iron chelator.
    Hamilton JL; Imran Ul-Haq M; Abbina S; Kalathottukaren MT; Lai BF; Hatef A; Unniappan S; Kizhakkedathu JN
    Biomaterials; 2016 Sep; 102():58-71. PubMed ID: 27322959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high-performance liquid chromatographic method for the measurement of deferoxamine in body fluids.
    Tesoro A; Leeder JS; Bentur Y; Klein J; Freedman M; Koren G
    Ther Drug Monit; 1989; 11(4):463-70. PubMed ID: 2741196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent insights into interactions of deferoxamine with cellular and plasma iron pools: Implications for clinical use.
    Porter JB; Rafique R; Srichairatanakool S; Davis BA; Shah FT; Hair T; Evans P
    Ann N Y Acad Sci; 2005; 1054():155-68. PubMed ID: 16339661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.
    Gosriwatana I; Loreal O; Lu S; Brissot P; Porter J; Hider RC
    Anal Biochem; 1999 Sep; 273(2):212-20. PubMed ID: 10469492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of fast atom bombardment mass spectrometry to biological samples: analysis of urinary metabolites of acetaminophen.
    Ackermann BL; Watson JT; Newton JF; Hook JB; Braselton WE
    Biomed Mass Spectrom; 1984 Oct; 11(10):502-11. PubMed ID: 6518270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.